首页 雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用

雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用

举报
开通vip

雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用 雾化吸入布地奈德治疗重度慢性阻塞性肺 疾病急性加重中的作用 [?????B??]1002-0179(2008)03-0519-02 ???B?S???1?X?q?????????????v NebulizedBudesonideintheTreatment ?4???v???????C?v?????I?????P ofAcuteExacerbationsofChronicObstructivePulmonaryDisease ?????a,??...

雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用
雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用 雾化吸入布地奈德治疗重度慢性阻塞性肺 疾病急性加重中的作用 [?????B??]1002-0179(2008)03-0519-02 ???B?S???1?X?q?????????????v NebulizedBudesonideintheTreatment ?4???v???????C?v?????I?????P ofAcuteExacerbationsofChronicObstructivePulmonaryDisease ?????a,?????? 3 ,?2??,?????m LIYan-wu,XUZhi-bo,BAOYong,etal. (?b???]?L?(???u?4??,?????b??X?610031) (TheThirdPeoplefnsHospitalofChengduCity,ChengduSichuan610031,China) X?X?????:????:?????1?X?q?????B???????????v?4???v???????C?v?????m???2???.?????P???FX]????:?(???? ??COPD?C?v?????m???2150?????;?-3??,?1?X?q?????????1?X?q?????B??2mg???B?S??,??8h1?A;???0 ?Z???;?????????????Z???;??????40mg???(????,???y1?A;???????5???P?????????P???fX]?????m?;48hX[7 dX]????:?1?X?q????X[?Z???;????????????????????,FEV1X[PaO2X[PaCO2?:???F???(?<???v???](P<0105); ?1?X?q????X[?Z???;?????????x???0???7?7?:???)?????F(P>0105),?#?1?X?q?????????P?N?<?????Z???;???? ????(P<0105)X]????:???B?1?X?q???????????(?q?:??AECOPD???z?j????,???q?N???0?Z???;?????????F, ?????????P?e,?????;???P???f?????????????(??X] ???Y??:???v?4???v??????;?1?X?q????????;?S??;?Z???;?????? [?I???-????]R563X?X?X?[???Y?7???[]A X?X?Abstract:Objective:Toevaluatetheclinicalefficacyofnebulizedbudesonide(NB)inacuteexacerbationsofchronicob2 structivepulmonarydisease(COPD).Methods:Patientswererandomlydividedintothreegroups.TheNSgroupreceivednebu2 lizedbudesonidebyexacerbationwith2mgevery8h.Theprednisolonegroupwastreatedwith40mgbyintravenouseveryday.The placebowasofferedcommontreatmentandnottreatedwithadrenocorticalhormones.Allgroupswereobservedfor48hand7d. Results:BothbudesonideandprednisoloneimprovedinFEV1X[PaO2andPaCO2wwhencomparedwithplacebo(P<0105).The differenceinFEV1X[PaO2X[PaCO2betweenbudesonideandprednisolonewasnotsignificant(P> 0105).Theoccurrenceofseri2 ousadverseintheNSgroupwerelowerthanthePSgroup(P<0105).Conclusion:Bothbudesonideand prednisoloneimproved obstruentairflowinCOPDpatientsNebulizedbudesonidemaybeanalternativetointravenouspredniso loneinthetreatmentof nonacidoticexacerbationsofCOPDwithloweradverseevents. Keywords:acuteexacerbationofchronicobstructivepulmonarydisease;budesonidesuspension;inhal ation;prednisolone (Receiveddate:2007-12-10) ??11( ??)?H/?????)(??)FEV1%PaO2mmHgPaCO2mmHg NS??6315??81732/181019??8153912??8175011??13194916??1213 PS??6412??61434/161110??5153715??7154918??12145019??1110 ??????6317??91932/181016??6193711??7115211??10195011??1119 P>0105>0105>0105>0105>0105>0105 ??21FEV1%X[FVC%X[PaO2X[PaCO2???? ??????D2D7 FEV1%NS?? PS?? ?????? 3912??817 3715??715 3711??711 4313??12133# 3911??14193 3715??1312 4610??13193# 4416??14113 3814??1412 PaO2mmHgNS?? PS?? ?????? 5011??1319 4918??1214 5211??1019 5715??13163# 5913??1019 3 5315??1211 6112??14133# 6111??1219 3 5612??1214 PaCO2mmHgNS?? PS?? ?????? 4916??1213 5019??1110 5011??1119 4611??9193# 4814??919 3 4917??1114 4019??10153# 4117??919 3 4915??918 ??:?N??????????:3P<0105;?NPS??????:#P>0105 ??31NS??X[PS???N???????????P?????? ???????R???????5?]?????%?R???????p NS??501(2%)2(4%)1(2%)1(2%) PS??508(16%)3 6(12%)3 4(8%)3 1(2%) ??:?NNS??????:3P<0105 X????2?????????a(6),??,?? ???b????,?4???4?9,?4??????X] X?3( COPD)?w???? ???vX[?b???v????X]COPD???2?????? ?C?v?????A????1??4?A [1] ,?????????2 ?????????BX[???????)??X[?????????m ?4?P???)??,?????C?v?????m???????? ?S????X]2006??COPD?Z?????1?A?? (GOLD???q)?7??COPD?C?v?????m?? ?2???m???????P?????P???f???:?????? ??,?y?????5????,???u?5????,???? ?m?4?P??,?????????P?????z???? (FEV1)<50%?????F???????5?C?v???? ??COPD???2???????P [2] X]?#???f???5 ?????????????????P???X???p,?z?.?? COPD?t?;?[????,?S?9??????????, ????????,?w?????P???????f?i?????? ??????,???3?????m?4?P???)??,?4?? ?:?P???? [3] X]????,?.???8?????????? ???????????????P???f??????????X] ???B?1?X?q?????P???.?????(?j?? ????X]???????4?v??,?????v??,?;?? ???S???v???f?P???w?z????????COPD ?g???m??????X]?p?3,?????B???(?u?? ?z?????????P?w?z????????COPD?C?v ?????m?????P [4??9] X]?:???z?????????? ???(?????5?3,?????z???I???P???B?1 ?X?q???M???1???;????1??8mgX]?L?z ???????????????P???f???B?S???????P ????COPD?C?v?????m?????q???????vX] 1X??????????? 111X??????(??:?(??2005??5?9?? ??5?9?????u????OD?C?v???? ?m???25??,???I?H??,??5??, ???G????6318??813??,????50??X]?? ?(?7??:(1)?O?9COPD?C?v?????m?? ???7?? [10] ,(2)1s?P?????4??(FEV1) <50%?3c?30%,(3)?R?z?-???;???? ?I??,(4)???????2X]?????7??:(1) ?????;?w?z??????,(2)?9???<?;???? ?v????,(3)???m???P?????P???f?B 3?y?????????P???????P???f,() ????????,?C?????>?????????(???f?? ?P??????,(5)????????,?????????5 ???k?????e???C??????,(6)?9?????S ?????????;???t?zX] 112X??????N????:???P????SEN2 SORMEDICS6200???????????????????W ??,?1?X?q?????B??????(?#???5:?? ???W???l,AstraZeneca?????m??)2mg ???B?S??(???PPARIBOYN???s???y ???B?S???;,?????????(???????m??) ,???0?P?Z???F???C??????(?#?? ?5?Z?;??,?????????m??)?? ?(????qX] 13X??????????-?????;?-???B?1 915?????4??2008,23(3)X?CN51-1356/R :197- : 2007CP 10982 04tid :40mg d 1:: (NS)??X[???0?Z???;?????? (PS)??????????3??,?-???(???)???q ?P??,NS???????1?X?q?????B??2mg ???B?S??,???y?(?A;PS???????Z???; ??????40mg/?y;???????5???P?????? ???P???fX]?????m?;7?y,?m???( GOLD???q?????w?z?????f?MX[???m?fX[ ??????X[?v???k?S??????,?#?5?????P ?????????????P???fX]?R?(?????-?,?P ???(??X[?????????N48hX[7d???????( ?R?z?-???????w?z?????f?M???P???N?? ?????W??X]???(?R?z?-???2???R?v?-?? (PaO2)X[???(???v?B???-??(PaCO2), ???????7?7???????P?????z???? (FEV1)?????BX]?????m???????????v ????,?????????P???f???????????P, ?2???????m???R?(?.???????????]?SX] ????????????????????????t???????? ???-??X]???????L?????4???O?-?????t ????,?p???0???5?????????C?????q, ?????????(?????????????3?e??X] 2X????? 211X?150?????2?????L?????-??,???? ?????????????0?-,P>0105X]?(???? ?????????P????X[???)X[FEV1%???R?z ?-???????????(?????v(??1)X] 212X??N?5???P???f????,NS????PS ???????(?R?z?????????7?7???5????X] PS????NS???????(?v?-??(PaO2)?? ???????P?????z????(FEV1)?G?<???? ?p,?x???????NFEV1??PaO2?G?(?N?< ?:??(P<0105),?x?????0?7?7?P?0?? ???????:???)?????F(P>0105),Pa2 CO2?F?:???)???????FX]?1?X?q?????? ??2mg/?AX[???y?(?A?S???????q?N?? ?0?Z???;??????40mg/?y????,?4???? ???????7?7FEV1%X[PaO2X[PaCO2?F?P ???)?0?????N?????????????]?(?<???v (??2)X] 213X????(???0???P???f???5???????t ???S?????f??(??3)X] 3X????? COPD?C?v?????m???????????4?? ?2???w?z?????f?MX[???m???k????(?( ?m????)?????????P???P???f?kX]?P COPD?C?v?????m???2?I?????????z?? ???????I?v??????????,?U?????????? ???????P?.???G??,?2?????x???????? 1?(TNF-1?),???(??B4(LTB4)???? ???f8(IL-8)?k,???P???f?????N?? ??COPD?C?v?????m???2?????z?????? ???I?v??????????TNF-1?X[LTB4X[IL -8?k???????P?.???)?? [2] X]???- COPD?C?v???????2???P?z???????v?? ?????v????????,?t???w?z???????4 ??,?????PCOPD?C?v?????m?z?????? ?????v??????????????COPD?g???m?? ??30?5 [11] ,???B,?????v???????g?? ??????(ECP)???,?????N?<???? COPD?g???mX]?PCOPD?C?v?????m?8 ???????????)?????????-????T?????? ?????-?????4?B????(RANTES)?<?? ?8?1,?zRANTES?N???4???????v???? ?????????????b?????? [12] X]???8???? ?????????????P???f?P????COPD?C?v ?????I?????PX]?L???z???<?;,?N?5?? ?P???f????,NS????PS???????(?R?z ?????????7?7???5????,???N???f???? ?(?qX]?NM?k [,,] ???z???????? ?FX]?t???????4???z?????N,???????P ?????P???f??????OD?C?v?????m?? ?2??????,?????????????5,?:?????v ?R??,???????m???5?????????U?C???? ??,?y???????????k [13,14] X]?p?3,?? ?P???????P???f???5???????w?<?3?i?? ??X]Niewoehner?k [14] ???J,AECOPD?? ?2???????P???F????30mg,2???N?R ???G??X[???>???????k?5?????????<?? ??????????X]???????v???P???P???f?P ??COPD?C?v?????m??????????/?p?? ???????????????????????w???(?C?? COPD???2?????w?3?????(?????????? ?[????X]?????????)?I?????.?(?t???? ????????,?????????S???m???P?????v ???P???f [15-19] X]???P???f???5?????? ?N???2?R???P???w???M???(??X]?w???M ???w???P???????P???f?????P?I?????? ???f [8,20,21] X]?????????????P?????v?? ?P???f???5???[?????P???H?(??,???m ???5???P?????2???m???P???????????? ???????N?<????X]???????P???f?d???? ?C?????????N?<???????2?m???P?????? ???????w??X]????,?????v???P???P?? ?f?P??COPD?C?v?????m???????m???? ??/?p???????????5??X] ???P???f?????B?S???????U???P?? ?u,?????5???????R???????3???????P ????????,???????q???3?5???????u, ?S???N???-???S?p??????,?#???A???( 85??90%???????????e????,?R???b?? ???c?????4?v????,????????????X]?L ?????????<?;,?1?X?q????????2mg/ ?AX[???y?(?A?S???????q?N???0?Z???; ??????40mg/?y????,?4???????????7 ?7FEV1%X[PaO2X[PaCO2?F?P???)?0?? ?????????<???v???]X]?z?N???????? ??,FEV1X[PaO2X[PaCO2?:???F???(?< ???v???]X]???N???B?S???1?X?q?????? ???????;???P???f?????????????(??X] ???(???0???P???f???5???????t???S?? ???f??,?L?????(?????2???????????C ??????,???5?????????????u,???m?? ?P???(?I??????X]????:???B???P???f ???????;????COPD???2?C?v?????m?? ?????????????(??X] ?L?????????????B?S???N???????P ???P???f?P???????I???v????COPD?C ?v?????m???(???F???q,?3?P???2?C?v ?????m??,???B?S???M?U???????u???5 ???????3?o???????v????X] 4X????1???Y: [1]MiriciA,MeralM,AkgunM.Comparisonof theefficacyofnebulisedbudesonidewith parenteralcorticosteroidsinthetreatmentof acuteexacerbationsofchronicobstructive pulmonarydisease[J].ClinDrugInvest, 2003,23(1):55-62. [2]NHLBI/WHOworkshopreport:Globalstrat2 egyfortheDiagnosis,Management,and PreventionofChronicobstructivePulmonary Disease.2006. [3]DecramerM,GosselinkR,TroostersT,et al.Muscleweaknessisrelatedtoutilization ofhealthcareresourcesinCOPDpatients [J].EurRespirJ,1997,10(4):417 -423. [4]LevyML,StevensonC,MaslenT.Comparison ofshortcoursesoforalprednisoloneandflu2 ticasonepropionateinthetreatmentofadults withacuteexacerbationsofasthmainprimary care[J].Thorax,1996,51:1087- [5]W,SS,LM,OfnB ,B,fO ffffzf2 []RM,, 93:689-699. [6]ManjraAI,PriceJ,LenneyW,HughesS, BarnacleH.Efficacyofnebulizedfluticas2 onepropionatecomparedwithoralpred2 nisoloneinchildrenwithanacuteexacerba2 tionofasthma[J].RespirMed,2000, 94:1206-1214. [7]MoriceAH,MorrisD,Lawson-MatthewP. Acomparisonofnebulizedbudesonidewith oralprednisoloneinthetreatmentofexacer2 bationsofobstructivepulmonarydisease [J].ClinPharmacolTher,1996,60: 675-678. [8]MaltaisF,OstinelliJ,TonnelAB,etal. Comparisonofnebulizedbudesonideandoral prednisolonewithplacebointhetreatmentof acuteexacerbationsofchronicobstructive pulmonarydisease:arandomizedcontrolled trial[J].AmJRespirCritCareMed, 2002,165(5):698-703. [9]???m,????.?1?X?q?????B?????P COPD?C?v?????m?????P[J].???P?. ???4???M??,2004,8(1):6-8. [10]?I???4???t???S?????-?t???v?4???v ??????????,???v?4???v?????????? ?7??[J].?I???????M??,2007,46 (3):254-261. [11]WhiteAJ,GompertzS,StockleyRA.Chronic obstructivepulmonarydisease[J].6:The aetiologyofexacerbationsofchronicobstruc2 tivepulmonarydisease[J].Thorax, 2003,58(1):73-78. [12]CelliBR,MacNeeW.ATS/ERSTaskForce. Standardsforthediagnosisandtreatmentpa2 tientswithCOPD:asummaryoftheATS/ ERSpositionpaper[J].EurRespirJ, 2004,23:932-946. [13]GorradoA,GoriniM,GinanniR,Pelagatti C,VillellaG,BuoncristianoU,GuidiF,of patientswithCOPD:asummaryofthe AST/ERSpositionpaper[J].EurRespir J,2004,23(6):932-946. [14]NiewoehnerDE,ErblandML,DeupreeRH, CollinsD,GrossNJ,LightRW,AndersonP, MorganNA.Effectofsystemicglucocorti2 coidsonexacerbationsofchronicobstructive pulmonarydisease[J].NEnglJMed, 1999,340:1941-1947. [15]DonaldsonGC,SeemungalTAR,Bhowmik A,WedzichaJA.Relationshipbetweenexac2 erbationfrequencyandlungfunctiondecline inchronicobstructivepulmonarydisease [J].Thorax2002,57:847-852. [16]DonaldsonGC,SeemungalTA,PatelIS,et al.Airwayandsystemicinflammationande2 clineinlungfunctioninpatientswithCOPD [J].Chest,2005,128:1995-2004. [17]AaronSD,VandemheenKL,HebertP,etal. Outpatientoralprednisoloneafteremergency treatmentofchronicobstructivepulmonary disease[J].NewEnglJMed,2003, 348:2618-2625. [18]DonaldsonGC,WilkinsonTMA,HurstJR, PereraWR,WedzichaJA.Exacerbationsand timespentoutdoorsinchronicobstructive pulmonarydisease[J].AmJRespirCrit CareMed,2005,171:446-452. [19]DonaldsonGC,SeemungalTAR,PatelIS,Lloyd -OwenSJ,WilkinsonTM,WedzichaJA,Lon2 gitudinalchangesinthenature,severityand frequencyofCOPDexacerbations[J].Eur RespirJ,2003,22:931-936. [20]WalshLJ,WongCA,OborneJ,etal.Ad2 verseeffectsoforalcorticosteroidsinrelation todoseinpatientswithlungdisease[J]. Thorax,2001,56:279-284. []WL,LS,W,T f yf[] RM,,66 665 (?p?>???m) 025WESTCHINAMEDICALJOURNAL2008,Vo1123,No13X?CN51-1356/R irici 189 CP 1092. estbroekJaarelainenaherrien JarnacleHEthimiouJ.ralsteroid- sparingeectotwodosesonebuliedluti casoneandplaceboinpatientswithsevere chronicasthmaJ.espired1999 21alshJewisAongCAetal.he impactooralcorticosteroiduseonbone mineraldensitandvertebralractureJ. AmJespirCritCareed20021: 91-9. :2007-12-10
本文档为【雾化吸入布地奈德治疗重度慢性阻塞性肺疾病急性加重中的作用】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑, 图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
该文档来自用户分享,如有侵权行为请发邮件ishare@vip.sina.com联系网站客服,我们会及时删除。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。
本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。
网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
下载需要: 免费 已有0 人下载
最新资料
资料动态
专题动态
is_841159
暂无简介~
格式:doc
大小:48KB
软件:Word
页数:0
分类:
上传时间:2018-04-13
浏览量:37